Related Experiment Video
Updated: Jun 12, 2025
08:49
Models of Bone Metastasis
Published on: September 4, 2012
42.0K
Disparities in Musculoskeletal Oncology
Abigail Koons1, Elyse Smith1, Jeffrey C Stephens1
1Department of Orthopaedic Surgery and Rehabilitation, University of Mississippi Medical Center, 2500 N State St, Jackson, MS, 39216, USA.
Current Reviews in Musculoskeletal Medicine
|September 24, 2024
Summary
Healthcare disparities negatively impact musculoskeletal oncology patients, affecting disease presentation and survival. Addressing modifiable and non-modifiable factors is crucial for improving patient outcomes in sarcoma care.
Area of Science:
- Oncology
- Healthcare Disparities
- Musculoskeletal Care
Background:
- Healthcare disparities create barriers to care, leading to adverse patient outcomes across all medical fields.
- These disparities are prevalent in musculoskeletal oncology, influencing patient access, presentation, and survival.
- Factors contributing to disparities include modifiable and non-modifiable elements impacting social determinants of health.
Purpose of the Study:
- To review the impact of healthcare disparities on musculoskeletal oncology.
- To identify factors contributing to these disparities in patient care.
- To highlight the need for research addressing disparities to improve patient outcomes.
Main Methods:
- Review of existing literature on healthcare disparities in musculoskeletal oncology.
- Analysis of factors correlating with disease presentation and survival.
- Identification of modifiable and non-modifiable disparity factors.
Main Results:
- Race, socioeconomic status, and insurance status are linked to advanced disease and poorer survival in sarcoma patients.
- Disparities complicate coordinated care delivery, essential for optimizing patient outcomes.
- Suboptimal short-term and long-term outcomes are observed in patients receiving musculoskeletal oncology care.
Conclusions:
- Healthcare disparities significantly affect musculoskeletal oncology patient outcomes.
- Further research is necessary to identify and address modifiable and non-modifiable factors.
- Improving patient outcomes requires targeted interventions to mitigate healthcare disparities.
Related Concept Videos
01:28Disorders of the Skeletal Muscle
903
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
903
01:29Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
02:49Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K